Julian Armstrong
Gastroenterology · Fort Worth, TXNPI 1972594745
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 34.1% of the total. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.
Across 227 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$336
- Johnson & Johnson$309
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$268
- Pfizer$204
- Bristol Myers Squibb$201
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,55295%
- Education$1735%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 82 | $1,269 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $336 |
| Johnson & Johnson(2 entities) | 23 | $309 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $268 |
| Pfizer | 12 | $204 |
| Bristol Myers Squibb | 11 | $201 |
| QOL Medical, LLC | 13 | $178 |
| Abbott | 1 | $128 |
| Ironwood Pharmaceuticals, Inc | 5 | $84 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| Sanofi | 3 | $74 |
| Daiichi Sankyo Inc. | 4 | $71 |
| Braintree Laboratories, Inc. | 4 | $69 |
| Merck | 4 | $69 |
| Janssen Scientific Affairs, LLC | 2 | $64 |
| Redhill Biopharma Inc. | 3 | $56 |
| Organon | 6 | $52 |
| Intercept Pharmaceuticals, Inc. | 3 | $47 |
| Ferring Pharmaceuticals Inc. | 3 | $36 |
| Ardelyx, Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| GI Supply, Inc. | 1 | $22 |
| Shionogi Inc | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| AstraZeneca | 1 | $14 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,725 in reported general payments places this provider in the 50th percentile of 1,350 gastroenterology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 14 | $10,579 |
| Omeprazole | 62 | $1,189 |
| Sucralfate | 16 | $482 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,269 | $10,57914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Fort Worth
- Tasneem AhmedFort Worth$215K
- Joseph SheltonFort Worth$71K
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.